Actively Recruiting
Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)
Led by Hospital de Basurto · Updated on 2024-10-22
88
Participants Needed
1
Research Sites
139 weeks
Total Duration
On this page
Sponsors
H
Hospital de Basurto
Lead Sponsor
E
Euskal Herriko Unibertsitatea. Universidad del Pais Vasco.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate if a nursing intervention based on the carbohydrate-insulin model can effectively reduce weight and manage the risk of metabolic syndrome (MetS) in individuals with first-episode psychosis. The main questions it aims to answer are: Will the intervention lead to a clinically significant weight loss (≥5%)? Can the intervention improve metabolic parameters, psychopathological state, physical activity level, and quality of life? Researchers will compare participants receiving the specialized nursing consultations to those receiving routine care to see if the former group experiences greater improvements in weight loss and metabolic risk reduction. Participants will: Attend a series of 8 nursing consultations focused on dietary habits based on the carbohydrate-insulin model and physical activity. Complete assessments at the start, 6 months, and 12 months, including weight, metabolic parameters, and psychological evaluations.
CONDITIONS
Official Title
Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients admitted to the Early Intervention Program (EIP)
- First-episode psychosis within the last 5 years
- Diagnosis of psychosis from the F2 spectrum or an affective disorder with psychotic symptoms according to ICD-10
You will not qualify if you...
- Cognitive inability to learn or comorbid intellectual disability that interferes with study procedures
- Comorbid diagnosis of neurological pathology
- Language or comprehension impairments preventing accurate data collection
- Use of hypoglycemic medication before or during the study
- Refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Universitario Basurto
Bilbao, Vizcaya, Spain, 48013
Actively Recruiting
Research Team
L
Lander Madaria
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here